Noank, CT, United States of America

Dane R Liston


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2000-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Dane R. Liston

Introduction

Dane R. Liston is an inventive mind hailing from Noank, Connecticut, with a significant contribution to the field of pharmaceuticals. With two patents to his name, Liston has focused on developing novel therapeutic solutions that leverage muscarinic receptor agonists to tackle diseases mediated by muscarinic receptor activity. His work reflects a commitment to advancing medical treatments through innovative approaches.

Latest Patents

Among his most notable inventions are two patents related to muscarinic receptor agonists. The first patent discusses a novel class of partial or full muscarinic receptor agonists, detailing intermediates for their preparation and the pharmaceutical compositions derived from these substances. This invention bears significant implications for the treatment or prevention of diseases that are affected by muscarinic receptor agonism. The second patent reiterates this focus, highlighting the transformative potential of his findings in medical applications.

Career Highlights

Dane R. Liston's career has been marked by his tenure at Pfizer Corporation, one of the largest pharmaceutical companies in the world. His experience at such a prestigious institution showcases his expertise in research and development, particularly in the area of therapeutic innovations.

Collaborations

Throughout his career, Liston has collaborated with esteemed professionals such as Anabella Villalobos and Daniel Yohannes. These partnerships underscore the importance of teamwork in the research and development of groundbreaking medical treatments.

Conclusion

In summary, Dane R. Liston has established himself as a significant inventor within the pharmaceutical sector, contributing valuable insights and innovations in muscarinic receptor agonists. His work is a testament to the power of invention in improving health outcomes and addressing medical challenges through scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…